Today's patients deserve better than yesterday's care.

It’s critical that lung cancer patients are aware of the resources available to them and the latest breakthroughs in research so they can make the most informed choices.

learn about your OPTIONS

Many lung cancer patients
don’t access the care they need.

Test Tubs Icons more info

Be part of the future of lung cancer treatment.

Clinical Trials are essential to study new innovations in cancer diagnosis and treatment. For lung cancer patients who volunteer to participate, they may represent an important treatment option, providing access to the newest, innovative approaches.

Beyond the possible benefit for individual patients, clinical trials are critical to moving science forward, to reach the next level of state-of-the-art care and treatment available for all lung cancer patients.

You’re never alone in your fight.

It is now easier than ever to research opportunities and open the conversation with your healthcare specialist.


Tony Goldwyn's Mom

"In 1993, I lost my mother to lung cancer. When she was diagnosed, she didn’t have many options. I was passionate about getting involved with Stand Up To Cancer because I want people to know that strides are being made in lung cancer research.

Through this PSA, we hope to motivate people diagnosed with this insidious disease to ask about all the options available to them."

-Tony Goldwyn, SU2C Ambassador


Share your story on Twitter and Instagram using the hashtag #StandUpToLungCancer

Today is your day.
Find more information about your options:

  • American Cancer Society
  • Lung Cancer Alliance
  • Lung Cancer Foundation of America
  • Free To Breathe
  • Lung Cancer Foundation
  • Lungevity

Lung Cancer Dream Team

  • Pasi A. Jänne

    Pasi A. Jänne, MD, PhD
    Director, Lowe Center for Thoracic Oncology and the Belfer Center for Applied Cancer Science, Dana-Farber Cancer Institute

  • Alice T. Shaw

    Alice T. Shaw, MD, PhD
    Director, Center for Thoracic Cancers, Massachusetts General Hospital Cancer Center (MGHCC)

  • Dr. Jedd Wolchok

    Jedd Wolchok, MD, PhD
    Chief of the Melanoma and Immunotherapeutics Service at Memorial Sloan Kettering Cancer Center in New York

Read more about our new SU2C-ACS Lung Cancer Dream Team here.